Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Astrazeneca Plc(AZN US)

$171.49-1.080.63%Ext:$169.17-2.321.35%(Market Closed · 00:00:04 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
AZN US​

Chronological SEC Filings

Non-Ownership Filings(1.9K)

Expand
  • 6-KULTOMIRIS APPROVED IN US IN IGAN22 Oct
  • 6-KASTRAZENECA COMPLETES EQUITY INVESTMENT IN SUMMIT5 Oct
  • 6-KAZ & DS COLLABORATION WITH SUMMIT FOR DATROWAY2 Oct
  • 6-KADMISSION OF FURTHER SECURITIES TO TRADING1 Oct
  • 6-KTOTAL VOTING RIGHTS1 Oct
  • 6-KASTRAZENECA ANNOUNCES EQUITY INVESTMENT IN SUMMIT29 Sep
  • 6-KTRIXEO APPROVED IN EU FOR ASTHMA23 Sep
  • 6-KKLYGEFA RECOMMENDED FOR EU APPROVAL BY CHMP21 Sep
  • 6-KENHERTU RECOMMENDED FOR APPROVAL IN EU IN EARLY BC21 Sep
  • 6-KDIRECTOR/PDMR SHAREHOLDING18 Sep
  • 6-KDIRECTOR/PDMR SHAREHOLDING15 Sep
  • 6-KDIRECTOR/PDMR SHAREHOLDING15 Sep
  • 6-KUPDATE ON SERENA-4 PHASE III TRIAL14 Sep
  • 6-KIMFINZI+IMDELLTRA IMPROVED OS IN SMALL CELL LUNG8 Sep
  • 6-KETCAMAH APPROVED IN THE US FOR HR+ BREAST CANCER8 Sep
  • 6-KADMISSION OF FURTHER SECURITIES TO TRADING1 Sep
  • 6-KTOTAL VOTING RIGHTS1 Sep
  • 6-KADMISSION TO TRADING - EUR2.55 BILLION BOND OFFERING1 Sep
  • 6-KENHERTU APPROVED IN EU FOR 1L HER2-POSITIVE MBC1 Sep
  • 6-KDIRECTORATE CHANGE1 Sep

Ownership Filings(130)

Expand
  • 4Sharma Mani8 Oct
  • 4Sharma Mani11 Sep
  • 4Sharma Mani7 Aug
  • 4Sharma Mani8 Jul
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun
  • 4Sharma Mani16 Jun
  • 4Sharma Mani22 May
  • 4Sharma Mani8 May
  • SC 13GASTRAZENECA PLC28 Apr
  • 3Sharma Mani19 Mar
  • SC 13G/AMonopar Therapeutics6 Feb
  • SC 13D/AInnate Pharma SA6 Feb
  • 144SARIN ARADHANA12 Nov 2025
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2025
  • SC 13G/AASTRAZENECA PLC23 Apr 2025
  • SC 13G/ACONDUIT PHARMACEUTICALS INC.10 Apr 2025
  • SC 13D/ACellectis S.A.24 Jan 2025
  • SC 13GMonopar Therapeutics28 Oct 2024
  • SC 13GCONDUIT PHARMACEUTICALS INC.11 Oct 2024
  • 11-KANNUAL REPORT26 Jun 2024